BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bettoni S, Shaughnessy J, Maziarz K, Ermert D, Gulati S, Zheng B, Mörgelin M, Jacobsson S, Riesbeck K, Unemo M, Ram S, Blom AM. C4BP-IgM protein as a therapeutic approach to treat Neisseria gonorrhoeae infections. JCI Insight 2019;4:131886. [PMID: 31661468 DOI: 10.1172/jci.insight.131886] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Laabei M, Colineau L, Bettoni S, Maziarz K, Ermert D, Riesbeck K, Ram S, Blom AM. Antibacterial Fusion Proteins Enhance Moraxella catarrhalis Killing. Front Immunol 2020;11:2122. [PMID: 32983170 DOI: 10.3389/fimmu.2020.02122] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Thofte O, Bettoni S, Su YC, Thegerström J, Jonsson S, Mattsson E, Sandblad L, Martí S, Garmendia J, Blom AM, Riesbeck K. Nontypeable Haemophilus influenzae P5 Binds Human C4b-Binding Protein, Promoting Serum Resistance. J Immunol 2021;207:1566-77. [PMID: 34433620 DOI: 10.4049/jimmunol.2100105] [Reference Citation Analysis]
3 Connolly KL, Pilligua-Lucas M, Gomez C, Costenoble-Caherty AC, Soc A, Underwood K, Macintyre AN, Sempowski GD, Jerse AE. Preclinical Testing of Vaccines and Therapeutics for Gonorrhea in Female Mouse Models of Lower and Upper Reproductive Tract Infection. J Infect Dis 2021;224:S152-60. [PMID: 34396408 DOI: 10.1093/infdis/jiab211] [Reference Citation Analysis]
4 Lin EY, Adamson PC, Klausner JD. Epidemiology, Treatments, and Vaccine Development for Antimicrobial-Resistant Neisseria gonorrhoeae: Current Strategies and Future Directions. Drugs 2021;81:1153-69. [PMID: 34097283 DOI: 10.1007/s40265-021-01530-0] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Shafiha R, Bahcivanci B, Gkoutos GV, Acharjee A. Machine Learning-Based Identification of Potentially Novel Non-Alcoholic Fatty Liver Disease Biomarkers. Biomedicines 2021;9:1636. [PMID: 34829865 DOI: 10.3390/biomedicines9111636] [Reference Citation Analysis]
6 Lewis LA, Ram S. Complement interactions with the pathogenic Neisseriae: clinical features, deficiency states, and evasion mechanisms. FEBS Lett 2020;594:2670-94. [PMID: 32058583 DOI: 10.1002/1873-3468.13760] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
7 Magda M, Bettoni S, Laabei M, Fairley D, Russo TA, Riesbeck K, Blom AM. Clinical Isolates of Acinetobacter spp. Are Highly Serum Resistant Despite Efficient Recognition by the Complement System. Front Immunol 2022;13:814193. [DOI: 10.3389/fimmu.2022.814193] [Reference Citation Analysis]
8 Bjanes E, Nizet V. More than a Pore: Nonlytic Antimicrobial Functions of Complement and Bacterial Strategies for Evasion. Microbiol Mol Biol Rev 2021;85:e00177-20. [PMID: 33504655 DOI: 10.1128/MMBR.00177-20] [Reference Citation Analysis]
9 Bettoni S, Maziarz K, Stone MRL, Blaskovich MAT, Potempa J, Bazzo ML, Unemo M, Ram S, Blom AM. Serum Complement Activation by C4BP-IgM Fusion Protein Can Restore Susceptibility to Antibiotics in Neisseria gonorrhoeae. Front Immunol 2021;12:726801. [PMID: 34539665 DOI: 10.3389/fimmu.2021.726801] [Reference Citation Analysis]
10 Elieh Ali Komi D, Shafaghat F, Kovanen PT, Meri S. Mast cells and complement system: Ancient interactions between components of innate immunity. Allergy 2020;75:2818-28. [PMID: 32446274 DOI: 10.1111/all.14413] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
11 Du Y, Xin H, Cao X, Liu Z, He Y, Zhang B, Yan J, Wang D, Guan L, Shen F, Feng B, He Y, Liu J, Jin Q, Pan S, Zhang H, Gao L. Association Between Plasma Exosomes S100A9/C4BPA and Latent Tuberculosis Infection Treatment: Proteomic Analysis Based on a Randomized Controlled Study. Front Microbiol 2022;13:934716. [DOI: 10.3389/fmicb.2022.934716] [Reference Citation Analysis]